1-(4-benzoylpiperazin-1-yl)-2-(naphthalen-1-yl)ethane-1,2-dione

ID: ALA4533962

PubChem CID: 5280312

Max Phase: Preclinical

Molecular Formula: C23H20N2O3

Molecular Weight: 372.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1cccc2ccccc12

Standard InChI:  InChI=1S/C23H20N2O3/c26-21(20-12-6-10-17-7-4-5-11-19(17)20)23(28)25-15-13-24(14-16-25)22(27)18-8-2-1-3-9-18/h1-12H,13-16H2

Standard InChI Key:  IZFXCOQJZCTIAK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    6.5167   -8.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8117   -9.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8194   -9.9071    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5250  -10.3110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2300   -9.8978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2294   -9.0806    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9344   -8.6674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6448   -9.0713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9290   -7.8502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6463   -9.8882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3558  -10.2921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0618   -9.8787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0537   -9.0574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3436   -8.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1144  -10.3204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4040   -9.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1198  -11.1376    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6990  -10.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3986   -9.0993    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9926   -9.9237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2881  -10.3363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2930  -11.1543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7100  -11.1431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0104  -11.5543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0176  -12.3640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7238  -12.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4241  -12.3472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4133  -11.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  8  1  0
  3 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 16 19  2  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22 24  1  0
 23 18  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 23  2  0
M  END

Associated Targets(Human)

MT2 (2907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 372.42Molecular Weight (Monoisotopic): 372.1474AlogP: 3.01#Rotatable Bonds: 3
Polar Surface Area: 57.69Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.05CX LogD: 3.05
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.02

References

1. Wang T, Wallace OB, Zhang Z, Fang H, Yang Z, Robinson BA, Spicer TP, Gong YF, Blair WS, Shi PY, Lin PF, Deshpande M, Meanwell NA, Kadow JF..  (2019)  A survey of core replacements in indole-based HIV-1 attachment inhibitors.,  29  (11): [PMID:30940396] [10.1016/j.bmcl.2019.03.018]

Source